Pharmacy Times

DECEMBER 23, 2022

From newsworthy moments to groundbreaking research, these are the most popular articles in the zoster space, published on Pharmacy Times® during 2022.

131

131

STAT

JUNE 20, 2024

In 2012, the Elsevier journal Personality and Individual Differences published a special issue that included articles with titles like “Life history theory and race differences: An appreciation of Richard Lynn’s contribution to science” and “National IQs and economic outcomes.”

29

29

STAT

MARCH 5, 2024

The article calls for a reframing of menopause and a management approach that is not simply focused on medical interventions that relieve symptoms. One in eight people is postmenopausal, and about 50 million women enter menopause every year.

143

143

pharmaphorum

AUGUST 12, 2024

Journal retracts three articles on MDMA-assisted psychotherapy, shortly after FDA blocks approval of @Lykos_PBC's therapy for PTSD

FDA 108

FDA 108

Policy Prescription

OCTOBER 22, 2024

They offer this advice in a new article in the Journal of the American Medical Association. Article Review The article, Strategies to Help Patients Navigate High Prescription Drug Costs , offers very digestible and evidence-driven guidance for clinicians to better assist their patients with the tangled web of drug pricing in America.

Insurance 113

Insurance Insurance Coverage Medical Schools FDA 113

Pharmacy Times

DECEMBER 26, 2022

This year, retail pharmacists were interested in diabetes research, saving patients money, and influenza vaccine candidates.

Vaccines 148

Vaccines 148

Fierce Pharma

JANUARY 6, 2024

A group of cell therapy experts, including CAR-T pioneers Drs. Bruce Levine and Carl June, wrote in support of continued use of CAR-T therapy.

FDA 132

FDA 132

PhRMA

FEBRUARY 21, 2023

Here are some recent articles exposing this issue: There have been some alarming stories uncovered by the media on ways nonprofit hospitals — many of which participate in the 340B drug pricing program — are taking advantage of the system and their tax-exempt status to boost their bottom lines, at the expense of patients.

Hospitals 231

Hospitals 231

Pharmaceutical Commerce

APRIL 8, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features.

105

105

Drug Topics

SEPTEMBER 21, 2024

Check out this recap of articles published on our sister sites during the past week.

Vaccines 187

Vaccines 187

Drug Topics

OCTOBER 5, 2024

Check out this recap of articles published on our sister sites during the past week.

Vaccines 187

Vaccines 187

Drug Topics

SEPTEMBER 28, 2024

Check out this recap of articles published on our sister sites during the past week.

186

186

IDStewardship

OCTOBER 27, 2022

In this article an infectious diseases pharmacist discusses antibiotic myths. Article posted 27 October 2022. Here is an article in BMJ that details the topic. Hopefully this article about antibiotic myths was helpful, now go be an antibiotic ninja ! Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP.

Labelling 364

Labelling FDA 364

Drug Topics

JUNE 6, 2023

A research article outlines the future of artificial intelligence in health care.

187

187

Drug Topics

DECEMBER 30, 2022

Take a look back at the top 15 articles that we published in 2022.

183

183

IDStewardship

OCTOBER 28, 2022

In this article a PGY2 Infectious Diseases Pharmacy Resident discusses social media as a resource for pharmacy residency recruitment, providing insights for both programs and candidates. . Article Posted 28 October 2022. While I strongly recommend reading the article, below are a few of the key takeaways. Authored by: Hunter O.

Documentation 246

Documentation 246

IDStewardship

DECEMBER 1, 2022

In this article a pharmacist with advanced training and experience in infectious diseases discusses five things pharmacists should know about ventilator associated pneumonia (VAP). Article Posted 1 December 2022. Authored By: Lucia Rose, PharmD, BCIDP.

Hospitals 348

Hospitals 348

STAT

JUNE 25, 2024

WASHINGTON — A journal published by the American Medical Association has corrected four articles from two of the nation’s top tobacco researchers, Ray Niaura and David Abrams, after STAT uncovered undisclosed ties the New York University professors had with the e-cigarette company Juul. Read the rest…

145

145

IDStewardship

DECEMBER 12, 2023

In this article a clinical pharmacist discusses ways that preceptors may integrate generative artificial intelligence programs into pharmacy education for student and resident learning experiences. Article posted 13 December 2023 Artificial intelligence is a hot topic today. Authored By: Timothy P. Gauthier, Pharm.D.,

Communication 305

Communication Patient Care 305

PharmaVoice

DECEMBER 20, 2024

The high drama of an election year, industry layoffs, patent cliff strategies and other key trends that shaped pharma in 2024.

59

59

STAT

SEPTEMBER 24, 2024

STAT is co-publishing this article by Tradeoffs. Lisa Ann Trainor struggled to stay on top of schoolwork, hold a job or even perform basic tasks like laundry for six exhausting years. Then, in 2018, she finally found a drug that kept her ADHD in check.    Continue to STAT+ to read the full story…

143

143

STAT

DECEMBER 11, 2023

The journal will also publish review articles, policy perspectives, and educational materials for physicians and computer scientists. Many recent articles published in top-tier journals have envisioned a future state where AI transforms vast swaths of medical practice.

141

141

IDStewardship

OCTOBER 14, 2024

In this article a pharmacist with experience in writing and publishing provides 5 quick tips for pharmacy residents preparing manuscripts Authored By: Timothy P. BCPS, BCIDP Article Posted October 2024, First Released in the June 2024 IDstewardship Newsletter Tip 1: Start by picking an article type and journal The article type (e.g.,

Documentation 130

Documentation Communication 130

STAT

JUNE 22, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

145

145

pharmaphorum

MARCH 12, 2024

Discover why gut bacteria are considered the next frontier in medicine in this informative article. Learn about the importance of the microbiome, its impact on health, and how it relates to conditions like Clostridiales difficile.

126

126

Fierce Healthcare

JULY 30, 2024

As artificial intelligence rapidly makes inroads in healthcare, federal agencies already have the authority to regulator AI at the hospital bedside, according to some healthcare researche | An article published in JAMA Health Forum argues that through the conditions of participation in Medicare and Medicaid, CMS has the authority to oversee how hospitals (..)

Hospitals 133

Hospitals Patient Care 133

STAT

OCTOBER 15, 2024

Nearly all of them, as a related article details, pointed to a crisis in primary care.    Over the last few months, STAT put that question to nearly a dozen experts in cardiology, primary care, endocrinology, and vascular disease.   Read the rest…

133

133

pharmaphorum

FEBRUARY 27, 2024

Learn more about why the industry is excited about radioisotopes in this article. Pharmaceutical companies are increasingly focusing on radiopharmaceuticals due to their potential in oncology and therapeutic applications.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies 122

Pharmacy Times

NOVEMBER 3, 2023

In an article by The New England Journal of Medicine, the authors discuss how drug companies could delay the approval of new oncology drugs under the IRA, delaying patient care.

Patient Care 132

Patient Care 132

STAT

JANUARY 10, 2023

Cell, EMBO, and Science have each opened their own investigations into the articles, and both Science and Cell have published “editorial expressions of concern” for the papers, which warn readers that the information in the articles may be questionable, but stop short of making corrections or retractions.

136

136

IDStewardship

OCTOBER 14, 2024

In this article an infectious diseases pharmacist discusses something cool and something lame with 5 antibiotics. BCPS, BCIDP Article Posted October 2024, First Released in the August 2024 IDstewardship Newsletter 1. Authored By: Timothy P. Gauthier, Pharm.D., It also has almost no use as monotherapy, which is also pretty sad.

130

130

STAT

OCTOBER 31, 2023

This article was adapted from STAT’s latest report , “Subgroup analysis: how to evaluate post hoc tests for significance in failed clinical trials.” ” C linical trials of newly developed drugs often don’t work out. Read the rest…

135

135

pharmaphorum

APRIL 2, 2024

Discover the importance of addressing menopause in the workplace and the benefits of hormone replacement therapy (HRT) through this insightful and informative article on breaking the stigma.

116

116

pharmaphorum

JANUARY 3, 2024

This article explores the efficacy, potential sales, and market trends in the field of obesity drugs. The race for obesity drug assets is becoming more intense as pharmaceutical companies strive to develop effective treatments for weight loss.

Pharmaceutical Companies 119

Pharmaceutical Companies Pharmaceutical Companies 119

pharmaphorum

FEBRUARY 22, 2024

Explore the benefits of these advancements in this insightful article. Discover how AI, automation, and blockchain technologies are revolutionising pharmaceutical case processing in compliance with FDA regulations.

FDA 116

FDA 116

European Pharmaceutical Review

JANUARY 2, 2024

To continue bridging the gaps between traditional and modern (enhanced) development approaches, the industry should attend regulatory expectations and pursue innovative frameworks that guarantee high-quality levels,” Simões et al. concluded.

Documentation 105

Documentation 105

pharmaphorum

AUGUST 1, 2024

Learn how to leverage AI for strategic advantage and stay ahead of the competition in this insightful article. Discover how AI is revolutionising the medical and pharmaceutical industries.

115

115